United States · FDA National Drug Code directory
AsperFlex MAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71399-4453_38f90910-7d3d-d442-e063-6394a90a3d66
- Product NDC
- 71399-4453
- Form
- PATCH
- Composition / generic term
- Lidocaine 4% with Menthol 1%
- Labeler
- Akron Pharma Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20211104
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE — 240 mg/1
- MENTHOL — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 PATCH in 1 CARTON (71399-4453-5) / 1 PATCH in 1 PATCH · 71399-4453-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →